Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| MLCO | PRESS-RELEASE | mixed | 5/10 | Melco Resorts reported Q2 2026 revenue of $1.25B, down 6% YoY, and GAAP EPS of $0.06 (vs consensus $0.08). Adjusted Prop | Aug 13, 2026 |
| ELMT | PRESS-RELEASE | bullish | 7/10 | The Elmet Group reported Q2 2026 revenue of $66.4M, a 35.2% YoY increase, significantly beating the $58.1M consensus. Ad | Aug 13, 2026 |
| FRMM | PRESS-RELEASE | mixed | 6/10 | Forum Markets reported Q2 2026 revenue of $1.4M, down sequentially from $2.9M in Q1 due to the elimination of digital as | Aug 13, 2026 |
| NXPL | PRESS-RELEASE | mixed | 6/10 | NextPlat reported Q2 2026 revenue of $11.9M, slightly above the $11.0M consensus, but EPS of -$0.42 missed the -$0.21 es | Aug 13, 2026 |
| ESEA | PRESS-RELEASE | bullish | 6/10 | Euroseas reported Q2 2026 EPS of $4.70, a 10.8% beat vs. the $4.24 consensus estimate, driven by strong container shippi | Aug 13, 2026 |
| PBLS | PRESS-RELEASE | bullish | 7/10 | Parabilis Medicines reported Q2 2026 results with a net loss of $52.5M, wider than the $34.8M loss in Q2 2025, driven by | Aug 13, 2026 |
| ASND | PRESS-RELEASE | bullish | 7/10 | Ascendis Pharma reported Q2 2026 product revenue of €315M (+105% YoY), driven by YORVIPATH (€252M) and SKYTROFA (€55M), | Aug 13, 2026 |
| POET | PRESS-RELEASE | bullish | 7/10 | POET reported Q2 2026 revenue of $569,925, up 112% YoY and 13% sequentially, with a net loss narrowing to ($0.07) per sh | Aug 13, 2026 |
| AEBI | PRESS-RELEASE | mixed | 6/10 | Aebi Schmidt reported Q2 2026 net sales of $496M (+9% YoY) and net income of $10.5M (vs -$7.9M loss a year ago), but GAA | Aug 13, 2026 |
| CLRB | PRESS-RELEASE | neutral | 4/10 | Cellectar Biosciences reported Q2 2026 net loss of $6.9M ($0.57/share) vs $5.4M ($3.39/share) in Q2 2025, with R&D spend | Aug 13, 2026 |
| ABEO | PRESS-RELEASE | mixed | 6/10 | Abeona reported Q2 2026 net ZEVASKYN revenue of $11.4M, up 31% QoQ, with five patients treated. However, EPS of -$0.35 m | Aug 13, 2026 |
| CRMD | PRESS-RELEASE | neutral | 5/10 | No summary provided | Aug 13, 2026 |
| GDS | PRESS-RELEASE | bullish | 7/10 | GDS reported Q2 2026 net revenue of RMB3,088M (+6.5% YoY) and net income of RMB837.6M vs a net loss of RMB70.6M a year a | Aug 13, 2026 |
| CREX | PRESS-RELEASE | mixed | 6/10 | Creative Realities reported Q2 2026 revenue of $21.5M (up 65% YoY) but a GAAP net loss of $(0.41) per share, widening fr | Aug 13, 2026 |
| NGEN | PRESS-RELEASE | neutral | 5/10 | NervGen Pharma reported Q2 2026 EPS of -$0.06, beating consensus of -$0.07 by 9.8%, but the company remains pre-revenue | Aug 13, 2026 |
| FTLF | PRESS-RELEASE | mixed | 5/10 | FitLife Brands reported Q2 2026 revenue of $26.5M (+65% YoY, beating $26.0M consensus) but diluted EPS of $0.20 missed t | Aug 13, 2026 |
| LUNR | PRESS-RELEASE | mixed | 6/10 | Intuitive Machines reported Q2 2026 revenue of $206.2M, over 4x the $50.3M in Q2 2025, driven by spacecraft production a | Aug 13, 2026 |
| CABA | PRESS-RELEASE | neutral | 4/10 | Cabaletta Bio reported Q2 2026 EPS of -$0.34, beating consensus of -$0.37 by 8.1%, with no revenue. The company highligh | Aug 13, 2026 |
| AFCG | PRESS-RELEASE | neutral | 4/10 | AFCG reported Q2 2026 GAAP net investment income of $3.5M ($0.15/share), down from $4.8M ($0.21/share) in Q1 2026. Total | Aug 13, 2026 |
| INKT | PRESS-RELEASE | mixed | 6/10 | MiNK Therapeutics reported Q2 2026 net loss of $3.1M ($0.62/share), improving from $4.2M ($1.06/share) in Q2 2025, with | Aug 13, 2026 |
| NOMD | PRESS-RELEASE | mixed | 5/10 | Nomad Foods reported Q2 2026 adjusted EPS of €0.39, beating consensus of €0.37 by 4.7%, but revenue declined 3.1% to €72 | Aug 13, 2026 |
| CLBT | PRESS-RELEASE | bearish | 6/10 | Cellebrite reported Q2 2026 non-GAAP EPS of $0.11, missing consensus of $0.11 by -2.5%, and revenue of $131.1M, slightly | Aug 13, 2026 |
| EU | PRESS-RELEASE | bearish | 6/10 | enCore Energy reported Q2 2026 results for the six months ended June 30, 2026, showing a net loss per share of $0.19 ver | Aug 13, 2026 |
| YJ | PRESS-RELEASE | neutral | 1/10 | Yunji Inc. announced it will report its first-half 2026 results on August 20, 2026. | Aug 13, 2026 |
| PULM | PRESS-RELEASE | bearish | 6/10 | Pulmatrix reported Q2 2026 financial results with minimal revenue, a net loss of $1.0M, and a cash burn that reduced its | Aug 13, 2026 |
| ZONE | PRESS-RELEASE | mixed | 6/10 | CleanCore Solutions (ZONE) announced the closing of a $100M public equity raise to fund its Minnesota AI data center cam | Aug 13, 2026 |
| OPEN | PRESS-RELEASE | neutral | 5/10 | Opendoor announced a $650M 0% convertible note offering due 2030, using $158M of proceeds to repurchase ~45.3M shares (5 | Aug 13, 2026 |
| MSGY | PRESS-RELEASE | bullish | 6/10 | Masonglory Limited (MSGY) entered a share swap agreement to acquire a 20% stake in Beta Beteiligungs und Besitz GmbH, a | Aug 13, 2026 |
| JD | PRESS-RELEASE | bullish | 7/10 | JD.com reported Q2 2026 revenue of RMB346.4B ($51.1B), down 2.9% YoY, a miss vs consensus of RMB342.67B. However, GAAP d | Aug 13, 2026 |
| XNET | PRESS-RELEASE | bearish | 6/10 | Xunlei reported Q2 2026 revenue of $102.7M (+38.9% YoY), but swung to a GAAP net loss of $218.5M from a $726.4M profit a | Aug 13, 2026 |